DUBLIN (AP) _ Horizon Therapeutics Public Limited Company (HZNP) on Wednesday reported first-quarter net income of $204.3 million, after reporting a loss in the same period a year earlier.

On a per-share basis, the Dublin-based company said it had net income of 87 cents. Earnings, adjusted for one-time gains and costs, came to $1.34 per share.

The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of $1.15 per share.

The drugmaker posted revenue of $885.2 million in the period, also surpassing Street forecasts. Five analysts surveyed by Zacks expected $866.9 million.

Horizon Therapeutics expects full-year revenue in the range of $3.9 billion to $4 billion.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on HZNP at https://www.zacks.com/ap/HZNP

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News